During the past decade, Advent Clinical Research Centers, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advent Clinical Research Centers, Inc." #1 sponsor was "Pfizer" with 10 trials, followed by "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "Endo Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advent Clinical Research Centers, Inc." #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Advent Clinical Research Centers, Inc." are "Osteoarthritis" (7 trials), "Arthritis" (3 trials), "Low Back Pain" (3 trials), "Acute Coronary Syndrome" (1 trials) and "Adhesive Capsulitis" (1 trials). Many other conditions were trialed in "Advent Clinical Research Centers, Inc." in a lesser frequency.

Most popular intervention types in "Advent Clinical Research Centers, Inc." are "Drug" (12 trials), "Biological" (11 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "tanezumab" (5 trials), "AA4500 0.29 mg/1 mL" (1 trials), "AA4500 0.58 mg/0.5 mL" (1 trials) and "AA4500 0.58 mg/1 mL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advent Clinical Research Centers, Inc." are 19 trials for "All" genders.

Currently, there are NaN active trials in "Advent Clinical Research Centers, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Advent Clinical Research Centers, Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Advent Clinical Research Centers, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".